Newsweek20d
FDA Approves Nasal Spray for Depression
The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...
Popular Science20d
FDA approves first-of-its-kind nasal spray for severe depression
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...
UPI20d
FDA approves Spravato, first monotherapy nasal spray to treat depression
Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...
pix1121d
Nose spray to treat depression? FDA approves first-of-its-kind medicine
NEW YORK (PIX11) – A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...
Interesting Engineering27d
MIT sets world record with 99.998% fidelity in quantum computing breakthrough
The team used timed pulses and a form of synthetic light to reduce errors and improve the accuracy of their quantum computer.
Daily Mail28d
How injections of a common household disinfectant could make cancer therapy work better: It's an incredible breakthrough, reveals THEA JOURDAN... and now it's being tested here
Injections of a common household disinfectant could help make radiotherapy more effective against some types of breast cancer. Hydrogen peroxide creates a toxic environment for cancer cells.